Zenas BioPharma, Inc.
ZBIO
$19.16
-$1.24-6.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.98% | 6.44% | -12.52% | -10.94% | -9.32% |
| Total Receivables | -7.69% | 0.00% | -23.53% | -15.00% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 52.06% | 10.79% | 7.94% | 21.55% | -56.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.38% | 6.47% | -12.34% | -10.71% | -9.61% |
|
|
|||||
| Total Current Assets | 18.38% | 6.47% | -12.34% | -10.71% | -9.61% |
| Net Property, Plant & Equipment | 61.96% | -19.98% | -16.07% | 7.32% | 118.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.05% | 17.00% | -8.18% | -0.06% | 41.14% |
| Total Assets | 19.14% | 9.87% | -12.19% | -9.79% | -8.29% |
|
|
|||||
| Total Accounts Payable | 10.35% | -18.75% | -60.38% | 16.82% | 13.62% |
| Total Accrued Expenses | 19.72% | 1.88% | 57.87% | -27.99% | 37.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 80.42% | -22.07% | -12.67% | 15.67% | 104.43% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -97.63% | -- |
| Total Other Current Liabilities | -- | -- | -- | -97.63% | -- |
| Total Current Liabilities | 19.51% | -1.55% | 8.37% | -14.24% | 30.22% |
|
|
|||||
| Total Current Liabilities | 19.51% | -1.55% | 8.37% | -14.24% | 30.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.22% | -16.28% | -32.18% | 45.41% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.74% | -- | -- | -- | -- |
| Total Liabilities | 12.67% | 134.93% | 8.11% | -14.02% | 30.71% |
|
|
|||||
| Common Stock & APIC | 39.68% | 1.16% | 1.10% | 0.78% | 0.79% |
| Retained Earnings | -45.83% | -10.88% | -12.41% | -8.67% | -15.71% |
| Treasury Stock & Other | 7.25% | 26.60% | -166.67% | -27.32% | 259.26% |
| Total Common Equity | 23.27% | -18.03% | -15.72% | -9.01% | -13.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.27% | -18.03% | -15.72% | -9.01% | -13.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.27% | -18.03% | -15.72% | -9.01% | -13.07% |
|
|
|||||